logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

David Penman Jacobus

This inventor holds 16 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Antimicrobial Compositions. Top assignees: Jacobus Pharmaceutical Company, Inc., Merck + Co., Inc., Jacobus Pharmaceuticals Company, Inc.. Active years: 1977-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Penman Jacobus. Retrieved from https://idiyas.com/inventor/david-penman-jacobus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 75.0

 

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 58(Granted Patents)


Company Filing History:

goldMedal8 out of 11 
 
Jacobus Pharmaceutical Company, Inc.
 patents
silverMedal7 out of 4,770 
 
Merck + Co., Inc.
 patents
bronzeMedal1 out of 2 
 
Jacobus Pharmaceuticals Company, Inc.
 patents

Years Active: 1977-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Heteroaryl Derivatives
Aryl Derivatives
Biguanide Derivatives
Antimalarial Compounds
Antibacterial Compositions
Dihydrotriazine Derivatives
Hydroxylamines
Sulfanilyl Phenyl Urea
Thiopeptin
Ruminant Feed
Cholecalciferol Derivatives
Mercaptopyridoxine
16 patents (USPTO):Explore Patents
1. 9409893 - Heteroaryl derivatives and uses thereof (2016-08-09),
2. 9296696 - Aryl derivatives and uses thereof (2016-03-29),
3. 8962657 - Aryl derivatives and uses thereof (2015-02-24),
4. 7563792 - Biguanide and dihydrotriazine derivatives (2009-07-21),
5. 7256218 - Biguanide and dihydrotriazine derivatives (2007-08-14),
6. 6693217 - Antimalarial N,N′-substituted biguanides derived from hydroxylamines (2004-02-17),
7. 6551614 - Antimalarial N,N′-substituted biguanides derived from hydroxylamines (2003-04-22),
8. 5658952 - 1-[4-(4'-sulfanilyl)phenyl]urea and derivatives for the treatment of (1997-08-19),
9. 5322858 - N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines (1994-06-21),
10. 4338334 - 1-[4-(4-Sulfanilyl)phenyl] urea and derivatives in compositions and (1982-07-06),
11. 4237116 - Combination of thiopeptin and rumensin to improve ruminant feed (1980-12-02),
12. 4069321 - Blocked cholecalciferol and dihydrotachysterol 3 derivatives (1978-01-17),
13. 4060639 - Broad spectrum antibacterial compositions containing (1977-11-29),
14. 4058625 - Broad spectrum antimicrobial compositions containing (1977-11-15),
15. 4058624 - Broad spectrum antibacterial compositions containing tris (1977-11-15),

Title: The Innovative Journey of David Penman Jacobus

Introduction

David Penman Jacobus, a prominent inventor based in Princeton, NJ, has made significant contributions to the field of pharmaceuticals with a strong focus on antimalarial compounds. With a remarkable portfolio of 16 patents, Jacobus continues to advance the fight against malaria, particularly the drug-resistant strains of the disease. His extensive work has positioned him as a key figure in pharmaceutical innovation.

Latest Patents

Among his latest innovations are two noteworthy patents:

1. **Heteroaryl derivatives and uses thereof** - This invention relates to antimalarial compounds and their application against protozoa of the genus Plasmodium, including drug-resistant strains. The patent encompasses compositions containing these compounds and outlines a process for their synthesis.

2. **Aryl derivatives and uses thereof** - Similar to his previous work, this patent also addresses antimalarial compounds and their efficacy against resistant strains of Plasmodium. It details compositions that leverage these compounds and includes methodologies for their preparation.

Career Highlights

Jacobus has had a fruitful career, having worked with notable pharmaceutical companies such as Jacobus Pharmaceutical Company, Inc. and Merck & Company, Inc. His tenure at these organizations has not only honed his skills as an inventor but has also allowed him to contribute to transformative medical advancements.

Collaborations

Throughout his career, Jacobus has collaborated with esteemed colleagues, including Norman P. Jensen and Guy Alan Schiehser. These partnerships have been instrumental in the development of innovative solutions for combating malaria and other health challenges.

Conclusion

David Penman Jacobus exemplifies the spirit of innovation through his dedicated work in pharmaceuticals. With a robust patent portfolio and numerous contributions to antimalarial research, he remains a pivotal figure in the ongoing battle against drug-resistant strains of malaria. His career serves as an inspiration for current and future inventors aiming to make a significant impact in the field of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…